Researchers from the Institute of Microbial Technology, Chandigarh, discovered a new prion called [SNG2] in fission yeast.
This discovery highlights the unexpected roles of prions in inheritance and cellular behaviour. @gmanjeera
Read here 👇
https://t.co/Wr1pa8APBk
RNA editing is in its nascent stage, yet there are already at least 11 biotechnology companies worldwide developing RNA editing methods for a range of diseases. Manjeera Gowravaram reports.
https://t.co/ANtkFJtBUT
India's precision medicine market is growing rapidly but it's biobank regulations could limit ts potential. Stronger laws will boost research, protect patient rights, and position India as a global leader in next-gen therapeutics. I write in The Hindu. https://t.co/Z0JS0GKfcK
Researchers at the @IITHyderabad have developed a device that can be 3D-printed and to screen drug combinations in oral cancer patients. 👨🔬 🇮🇳
✍️ @gmanjeera
Read the article 👇
https://t.co/HNokeQJJyw
In this article Viraj and I write the need to establish organ-in-chip centers for advancement in medical research and to boost the bioeconomy. https://t.co/R8jWFixRsW
Very happy that this story (a team effort by @Grant49715112, @a_machadoamorim, @VinneMacc and others) is out! What was initially one strange observation is now a report of how a helicase dissociates from its RNA substrate upon activation. Warning: no mechanism proposed!
While vaccine availability, production and delivery are being worked, we believe it is equally critical to focus on procuring adequate human resources.
How do we create the Human Resources required to vaccinate a population the size of India against a pandemic? Leverage medical students. A plan from @gmanjeera@SameerWagle1 and yours truly. https://t.co/LVG5GbatwZ
Why the old, comorbid, children & those who WFH shouldn’t be first in line for Covid vaccine
Biochemist and Postdoctoral fellow Manjeera Gowravaram @gmanjeera writes
#ThePrintOpinion
https://t.co/sNLfX7qOv0
Given production limits, India will need to have a prioritisation strategy to deploy any approved COVID-19 vaccine. Read this excellent piece by @gmanjeera on why we should vaccinate our healthcare and essential workers first. @TakshashilaInst@acorn@pranaykotas@SunilaDixit
My article in @ThePrintIndia talks about how India needs to adopt a prioritization strategy to vaccinate it's people against COVID-19.
https://t.co/YRWTpAzn0x